Total—n | 432 |
---|---|
Registered within KHDSS—n (%) | 398 (92) |
Route of HIV testing—n (%) | |
CRH | 203 (47) |
HIV serosurvey | 181 (42) |
Missing | 48 (11) |
Sex—n (%) | |
Male | 189 (44) |
Female | 243 (56) |
Age—n (%) | |
15–34 | 162 (38) |
≥35 | 270 (63) |
Median age—years | 38.0 |
Weight—kg | |
Median (IQR) | 52.9 (46.8–58.4) |
Missing—n (%) | 12 (3) |
Median BMI | 20.1 |
Year of ART initiation—n (%) | |
2008 | 150 (35) |
2009 | 106 (25) |
2010 | 117 (27) |
2011 | 59 (14) |
WHO stage—n (%) | |
1 | 49 (11) |
2 | 134 (31) |
3 | 203 (47) |
4 | 46 (11) |
CD4 count—n (%) cells/μL | |
≤250 | 285 (66) |
251–350 | 33 (8) |
351–500 | 14 (3) |
>500 | 9 (2) |
Missing | 91 (21) |
Median CD4 count—cells/μL (IQR) | |
Overall | 156 (77–227) |
By route of HIV testing | |
CRH | 139 (62–222) |
HIV serosurvey | 167 (108–227) |
Missing | 169 (69–244) |
Starting Regimen—n (%) | |
d4T-3TC-NVPa | 431 (99.8) |
TDF-3TC-EFVb | 1 (0.2) |
Clinical Details—n (%) | |
Weight loss >10Â % | 107 (25) |
Oral candidiasis | 74 (17) |
Severe bacterial infection | 72 (17) |
Unexplained fever >1Â month | 32 (7) |
Wasting syndrome | 14 (3) |
Pulmonary tuberculosis | 12 (3) |
Kaposi’s sarcoma | 10 (2) |
Oesophageal candidiasis | 9 (2) |
Extrapulmonary tuberculosis | 5 (1) |